CH587850A5 - - Google Patents

Info

Publication number
CH587850A5
CH587850A5 CH1124073A CH1124073A CH587850A5 CH 587850 A5 CH587850 A5 CH 587850A5 CH 1124073 A CH1124073 A CH 1124073A CH 1124073 A CH1124073 A CH 1124073A CH 587850 A5 CH587850 A5 CH 587850A5
Authority
CH
Switzerland
Application number
CH1124073A
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH587850A5 publication Critical patent/CH587850A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH1124073A 1973-07-11 1973-08-02 CH587850A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2335170A DE2335170C2 (de) 1973-07-11 1973-07-11 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH587850A5 true CH587850A5 (fr) 1977-05-13

Family

ID=5886518

Family Applications (4)

Application Number Title Priority Date Filing Date
CH1602476A CH587851A5 (fr) 1973-07-11 1973-08-02
CH1602376A CH587852A5 (fr) 1973-07-11 1973-08-02
CH1124073A CH587850A5 (fr) 1973-07-11 1973-08-02
CH1602576A CH587853A5 (fr) 1973-07-11 1973-08-02

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH1602476A CH587851A5 (fr) 1973-07-11 1973-08-02
CH1602376A CH587852A5 (fr) 1973-07-11 1973-08-02

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1602576A CH587853A5 (fr) 1973-07-11 1973-08-02

Country Status (17)

Country Link
US (1) US4108995A (fr)
AR (4) AR199915A1 (fr)
AT (1) AT333300B (fr)
BE (1) BE816869R (fr)
CA (1) CA1062709A (fr)
CH (4) CH587851A5 (fr)
DE (1) DE2335170C2 (fr)
DK (1) DK147004C (fr)
ES (3) ES417828A1 (fr)
FI (1) FI61703C (fr)
FR (1) FR2236501B2 (fr)
GB (1) GB1480836A (fr)
IE (1) IE41822B1 (fr)
NL (1) NL168703C (fr)
NO (2) NO140596C (fr)
SE (1) SE415354B (fr)
ZA (1) ZA744373B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207321A (en) * 1977-04-02 1980-06-10 Hoechst Aktiengesellschaft Pharmaceutical compositions containing xanthines
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
DE3942871A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
EP0570831A2 (fr) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Utilisation de dérivés de Xanthine pour le traitement de dommages cérébraux après interruption de la circulation sanguine
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
DE926788C (de) * 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
AR202662A1 (es) 1975-06-30
BE816869R (fr) 1974-12-27
ES417828A1 (es) 1976-03-16
CA1062709A (fr) 1979-09-18
IE41822B1 (en) 1980-04-09
ES437151A1 (es) 1977-01-16
NO790627L (no) 1975-01-14
AR202663A1 (es) 1975-06-30
NL7311123A (nl) 1975-01-14
AT333300B (de) 1976-11-10
NL168703C (nl) 1982-05-17
US4108995A (en) 1978-08-22
GB1480836A (en) 1977-07-27
AR200626A1 (es) 1974-11-22
NO140596C (no) 1979-10-03
ZA744373B (en) 1975-07-30
DK438373A (fr) 1975-03-03
CH587853A5 (fr) 1977-05-13
SE415354B (sv) 1980-09-29
NL168703B (nl) 1981-12-16
FI206574A (fr) 1975-01-12
AR199915A1 (es) 1974-10-08
DK147004B (da) 1984-03-12
NO143064B (no) 1980-09-01
AU7101974A (en) 1976-01-15
ES437150A1 (es) 1977-01-16
DK147004C (da) 1984-08-20
FR2236501B2 (fr) 1979-08-10
FR2236501A2 (fr) 1975-02-07
FI61703C (fi) 1982-09-10
NO143064C (no) 1980-12-10
NO140596B (no) 1979-06-25
CH587851A5 (fr) 1977-05-13
CH587852A5 (fr) 1977-05-13
IE41822L (en) 1975-01-11
FI61703B (fi) 1982-05-31
DE2335170C2 (de) 1989-07-20
ATA684573A (de) 1976-03-15
DE2335170A1 (de) 1975-01-30
NO742464L (fr) 1975-02-10
SE7310986L (sv) 1975-01-13

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU465372B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
FR2236501B2 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU477823B2 (fr)
AU471461B2 (fr)
AU476873B1 (fr)
AU477824B2 (fr)
AU479562A (fr)
AU479539A (fr)
AU479422A (fr)
AU470923A (fr)
AU479458A (fr)
AU479405A (fr)
CH565464A5 (fr)
AU479496A (fr)

Legal Events

Date Code Title Description
PL Patent ceased